l.osei
TL2 Moderator · Cork
Contributes reviews on supplier material. Based in Cork.
Joined 25 February 2025 · last posted 9d
86 posts, newest first. Showing up to 150.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #11 · Compounds › Tirzepatide · 19 Jul 2026 · 5 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Blinding yourself: practical methods and their limits Replied, post #42 · Research Methods › N-of-1 designs · 13 Jul 2026 · 12 likes Coming back to post #40, because the follow-up matters more than the original answer. Stopping rules: decide in advance when you will stop measuring (after a defined…
-
What I would want from a home test that does not exist yet Replied, post #33 · Analytics › Home & field testing · 10 Jul 2026 · 0 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Seven-day rolling means and why weekly readings mislead Replied, post #6 · Outcomes › Progress reports · 10 Jul 2026 · 0 likes post #5 answers the question as asked. The question underneath it is different. Protein intake and resistance training: both self-reported and therefore optimistic in…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #50 · Compounds › Retatrutide · 10 Jul 2026 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #32 · Evidence › Journal club · 7 Jul 2026 · 0 likes This follows post #29 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #97 · Safety › Contraindications · 3 Jul 2026 · 33 likes On post #93 — agreed on the reasoning, with one qualification. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication…
-
Tracking a shortage from primary sources rather than rumour Replied, post #82 · Access › Shortages · 3 Jul 2026 · 0 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Follow-up: Signs of dehydration worth acting on Replied, post #12 · Safety › Adverse events · 3 Jul 2026 · 0 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #39 · Analytics › Home & field testing · 23 Jun 2026 · 1 like Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #21 · Outcomes › Body composition · 18 Jun 2026 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #24 · Analytics › COA interpretation · 7 Jun 2026 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #118 · Compounds › Tirzepatide · 2 Jun 2026 · 18 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Follow-up: Sleep quality changes during weight loss Replied, post #15 · Wellbeing › Sleep · 3 May 2026 · 30 likes Worth separating two things that post #11 runs together. Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that…
-
What a good consultation looks like from the other side Replied, post #33 · Clinical › Prescriber conversations · 19 Apr 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #39 · Devices › Syringes & needles · 18 Apr 2026 · 17 likes Coming back to post #37, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #2 · Documentation › Doc review · 16 Apr 2026 · 10 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #125 · Pharmacology › Pharmacokinetics · 6 Apr 2026 · 12 likes post #124 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #11 · Compounds › Retatrutide · 31 Mar 2026 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #77 · Clinical › Special populations · 18 Mar 2026 · 9 likes I read post #75 twice before replying, because I had assumed the opposite. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist…
-
A site rotation scheme that is easy enough to actually follow Replied, post #22 · Practice › Administration · 18 Mar 2026 · 8 likes On post #18 — agreed on the reasoning, with one qualification. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether…
-
Reused chromatograms across lots: how to spot it Replied, post #24 · Analytics › COA interpretation · 4 Mar 2026 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #47 · Evidence › Trials · 15 Feb 2026 · 0 likes Picking up post #44: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
MHRA statements, read directly Replied, post #82 · Regional › UK & Ireland · 4 Feb 2026 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #31 · Pharmacology › Pharmacokinetics · 2 Feb 2026 · 31 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Reading an interaction checker output critically Replied, post #101 · Practice › Interactions · 25 Jan 2026 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #7 · Clinical › Special populations · 20 Jan 2026 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #68 · Clinical › Special populations · 5 Jan 2026 · 12 likes post #67 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Cost per delivered dose, which is the number that matters Replied, post #35 · Access › Pricing · 1 Jan 2026 · 1 like post #34 is right about the mechanism and I think understates the practical bit. Insurance tier placement: a compound might be covered but on a higher tier (higher…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #76 · Practice › Interactions · 25 Dec 2025 · 12 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 25 Dec 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #47 · Compounds › Semaglutide · 22 Dec 2025 · 23 likes Coming back to post #45, because the follow-up matters more than the original answer. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #18 · Access › International · 19 Dec 2025 · 28 likes post #17 is right about the mechanism and I think understates the practical bit. Insurance and coverage: coverage decisions are national. A compound approved in one…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #6 · Analytics › COA interpretation · 17 Dec 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #26 · Pharmacology › Pharmacokinetics · 26 Nov 2025 · 1 like Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Lurking for two months before posting: was that the right call? Replied, post #50 · Start Here › Welcome · 19 Nov 2025 · 4 likes I read post #48 twice before replying, because I had assumed the opposite. The moderation log is public. Every staff action is logged with the rule cited and the…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #32 · Sourcing › Regulatory · 15 Nov 2025 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Pen dose counters: what a click does and does not guarantee Replied, post #30 · Devices › Pens & autoinjectors · 14 Nov 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #78 · Start Here › How to Ask · 10 Nov 2025 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #109 · Safety › Adverse events · 9 Nov 2025 · 0 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Amylin receptor signalling and satiety Replied, post #26 · Pharmacology › Receptor biology · 2 Nov 2025 · 12 likes post #25 is right about the mechanism and I think understates the practical bit. Central versus peripheral action: GLP-1 agonism works through both central nervous…
-
Follow-up: What a seizure notice actually says Replied, post #37 · Sourcing › Logistics · 27 Oct 2025 · 6 likes Coming back to post #35, because the follow-up matters more than the original answer. At what point is a parcel genuinely a problem: if it was despatched weeks ago and…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #15 · Analytics › Impurities & related substances · 23 Oct 2025 · 29 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
What a purity-only report leaves out Replied, post #55 · Sourcing › Independent verification · 21 Oct 2025 · 3 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Thyroid function tests during substantial weight change Replied, post #92 · Clinical › Bloodwork · 11 Oct 2025 · 1 like This follows post #89 rather than contradicting it. Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #64 · Practice › Reconstitution · 5 Oct 2025 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Documentation that appears only after payment Replied, post #37 · Sourcing › Red flags · 30 Sep 2025 · 5 likes post #36 answers the question as asked. The question underneath it is different. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #84 · Analytics › HPLC & UHPLC · 26 Sep 2025 · 14 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #29 · Outcomes › Progress reports · 20 Sep 2025 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #65 · Analytics › HPLC & UHPLC · 10 Sep 2025 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #92 · Evidence › Journal club · 10 Sep 2025 · 0 likes Picking up post #89: that is the part I would want checked first. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #45 · Compounds › Secretagogues & GH axis · 8 Sep 2025 · 5 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #71 · Evidence › Journal club · 3 Sep 2025 · 4 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
A ten-fold dose error caught before injection Replied, post #76 · Devices › Syringes & needles · 4 Aug 2025 · 27 likes On post #72 — agreed on the reasoning, with one qualification. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #97 · Practice › Storage & stability · 27 Jul 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What I would record differently if I started again — the long version Replied, post #5 · Outcomes › Progress reports · 23 Jul 2025 · 28 likes Worth separating two things that the opening post runs together. Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain)…
-
Temperature loggers worth the money Replied, post #10 · Devices › Cold chain · 18 Jul 2025 · 15 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #4 · Analytics › HPLC & UHPLC · 7 Jul 2025 · 3 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #10 · Evidence › Meta-analyses · 24 Jun 2025 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Repeatability versus intermediate precision Replied, post #51 · Analytics › Method validation · 24 Jun 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #78 · Access › Insurance & coverage · 12 Jun 2025 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #45 · Nutrition & Training › Protein & intake · 8 Jun 2025 · 11 likes Coming back to post #43, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Needle changes between doses on a reusable pen — does this still hold? Replied, post #4 · Devices › Pens & autoinjectors · 6 Jun 2025 · 27 likes This follows post #2 rather than contradicting it. Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct…
-
An orphaned page with no inbound links Replied, post #44 · Meta › Wiki maintenance · 23 May 2025 · 0 likes Picking up post #41: that is the part I would want checked first. Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #70 · Data & Tools › Calculators · 15 May 2025 · 4 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #96 · Evidence › Journal club · 21 Apr 2025 · 18 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Follow-up: What other technical communities get right that we do not Replied, post #68 · Lounge › Off topic · 15 Apr 2025 · 33 likes This follows post #65 rather than contradicting it. Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta)…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #50 · Practice › Reconstitution · 14 Apr 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Fibre intake when total intake falls, and the constipation link Replied, post #51 · Nutrition & Training › Protein & intake · 9 Apr 2025 · 5 likes Picking up post #48: that is the part I would want checked first. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #22 · Sourcing › Vendor reports · 15 Mar 2025 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #67 · Compounds › Semaglutide · 17 Feb 2025 · 16 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #7 · Practice › Dosing & titration · 4 Feb 2025 · 11 likes post #6 is right about the mechanism and I think understates the practical bit. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #29 · Evidence › Journal club · 28 Jan 2025 · 13 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
What changed in 2026, by region Replied, post #89 · Access › International · 20 Jan 2025 · 1 like post #88 answers the question as asked. The question underneath it is different. Regulatory position dates: a regulatory position is only current as of when it was…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #4 · Access › International · 18 Jan 2025 · 22 likes I read post #3 twice before replying, because I had assumed the opposite. Currency and exchange rates: paying in different currencies has different costs and risks.…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #30 · Analytics › Mass spectrometry · 3 Jan 2025 · 2 likes Coming back to post #28, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #59 · Compounds › Oral incretins · 27 Dec 2024 · 10 likes Picking up post #56: that is the part I would want checked first. Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #3 · Practice › Reconstitution · 25 Dec 2024 · 21 likes post #2 answers the question as asked. The question underneath it is different. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives…
-
About the Wiki requests category Replied, post #5 · Documentation › Wiki requests · 19 Dec 2024 · 13 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
A promotion I argued against, and why I lost Replied, post #13 · Documentation › Doc review · 25 Nov 2024 · 11 likes Worth separating two things that post #9 runs together. New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #27 · Nutrition & Training › Resistance training · 17 Nov 2024 · 2 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Time to steady state after a dose increase Replied, post #57 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #39 · Wellbeing › Mental health · 19 Oct 2024 · 1 like Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Blind submission and why it changes minds Replied, post #65 · Sourcing › Independent verification · 19 Sep 2024 · 1 like Coming back to post #63, because the follow-up matters more than the original answer. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #6 · Safety › Contraindications · 2 Sep 2024 · 5 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Progressive overload when the scale is falling — one year on Replied, post #2 · Nutrition & Training › Resistance training · 23 Aug 2024 · 6 likes the opening post answers the question as asked. The question underneath it is different. Volume: the number of sets per muscle group per week that supports muscle…